Skip to main content

Erratum to: Detection of ATM germline variants by the p53 mitotic centrosomal localization test in BRCA1/2-negative patients with early-onset breast cancer

The Original Article was published on 06 September 2016

Erratum

In original publication of this article [1], the data for “Pat#7” in Additional file 1 was listed as “c.4436+24G>A” in the “Nucleotide change” column. Instead, the number should have been c.4436+24A>G.

Reference

  1. Prodosmo A, et al. Detection of ATM germline variants by the p53 mitotic centrosomal localization test in BRCA1/2-negative patients with early-onset breast cancer. J Exp Clin Cancer Res. 2016;35:135. doi:10.1186/s13046-016-0410-3.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Giuseppe Giannini or Silvia Soddu.

Additional information

The online version of the original article can be found under doi:10.1186/s13046-016-0410-3.

The online version of the original article can be found at http://dx.doi.org/10.1186/s13046-016-0410-3.

Additional file

Additional file 1:

Characteristics of ATM variants. (DOCX 16 kb)

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Prodosmo, A., Buffone, A., Mattioni, M. et al. Erratum to: Detection of ATM germline variants by the p53 mitotic centrosomal localization test in BRCA1/2-negative patients with early-onset breast cancer. J Exp Clin Cancer Res 35, 185 (2016). https://doi.org/10.1186/s13046-016-0459-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13046-016-0459-z